9th Jun 2009 07:00
|
For immediate release |
9 June 2009 |
RNS REACH
ALLIANCE PHARMA PLC
("Alliance Pharma" or "the Company")
Growth Company Investor Show
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, is hosting a corporate exhibition stand at the Growth Company Investor Show to be held at The Barbican Exhibition Halls, London, on Wednesday 10 June 2009.
Members of the Company's management team look forward to welcoming investors and potential investors to Stand No 66 and providing an insight into recent progress at the Company.
At its recent AGM, Alliance Pharma reported that trading in the first four months of 2009 was "ahead of our expectations and significantly ahead of last year " and reiterated its intention "to pay a maiden dividend within the year".
Alliance Pharma's annual report, and further information about the Company, is available at theCompany's website, www.alliancepharma.co.uk.
Further information about the Growth Company Investor Show is available atwww.growthcompanyinvestorshow.co.uk/show/ .
For further information:
|
Alliance Pharma plc
|
+ 44 (0) 1249 466966
|
|
John Dawson, Chief Executive
|
|
|
Richard Wright, Finance Director
|
|
|
www.alliancepharma.co.uk
|
|
|
|
|
|
Buchanan Communications
|
+ 44 (0) 20 7466 5000
|
|
Mark Court / Rebecca Skye Dietrich / Stasa Filiplic
|
|
Related Shares:
Alliance Pharma